BIOMILQ Funding & Investors
We leverage our patent-pending technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.
biomilq.comTotal Amount Raised: $24,500,000
BIOMILQ Funding Rounds
Series A
$21,000,000
Series A Investors
Novo HoldingsGaingelsDigitalis VenturesSpero VenturesBreakthrough Energy VenturesBlue HorizonAlexandriaGreen Generation FundSeed
$3,500,000
Seed Investors
Breakthrough Energy VenturesBlue HorizonPurple Orange VenturesShazi Visram
Funding info provided by Diffbot.